Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition containing lappaconitine and oxycodone

A kind of technology of clathrin and clathrate hydrobromide, which is applied in the field of medicine

Active Publication Date: 2013-04-17
BEIJING HUMANWELL JUNWEI PHARM TECH CO LTD
View PDF2 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

After long-term injection of homo-urinine to monkeys, the monkeys do not appear any withdrawal syndrome after stopping the drug. After long-term injection of LH to mice, and then given acrylmorphine to induce addiction, there is no jumping reaction, but LH has no effect on morphine-dependent rats. or withdrawal symptoms after drug withdrawal in monkeys without substitution

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition containing lappaconitine and oxycodone
  • Pharmaceutical composition containing lappaconitine and oxycodone
  • Pharmaceutical composition containing lappaconitine and oxycodone

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062] Embodiment 1——tablet containing homogenate and oxycodone

[0063] prescription:

[0064] Tablets:

[0065]

[0066] Film Coating Prescription:

[0067]

[0068]

[0069] Preparation method: pass the prescribed amount of urine, oxycodone, microcrystalline cellulose and 200g starch through an 80-mesh sieve and mix evenly, use 10% PVP K-30 aqueous solution as a binder to make granules and dry, dry Mix the granules with the rest of dried starch and micropowder silica gel, and press plain tablets with different weights, each tablet contains 10mg / 10mg, 5mg / 5mg, or 2.5mg / 2.5mg of oxycodone . Then coat the plain tablet again until the weight of the tablet increases by 3-4%.

Embodiment 2

[0070] Embodiment 2——tablet containing homogenate and oxycodone

[0071] prescription:

[0072]

[0073] Preparation method: pass the prescribed amount of urine, oxycodone, microcrystalline cellulose and 200g starch through an 80-mesh sieve and mix evenly, use 10% PVP K-30 aqueous solution as a binder to make granules and dry, dry The granules are mixed with the rest of dried starch and micropowder silica gel, and tablets of different weights are compressed. Each tablet contains 5 mg / 10 mg, 2.5 mg / 5 mg, or 1.25 mg / 2.5 mg / oxycodone respectively mg.

Embodiment 3

[0074] Embodiment 3——tablet containing homogenate and oxycodone

[0075] prescription:

[0076]

[0077]

[0078] Preparation method: refer to the method of Example 2 to prepare granules and compress into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition containing lappaconitine and oxycodone for treating pain. The pharmaceutical composition contains a treatment effective quantity of lappaconitine or a pharmaceutically acceptable salt thereof or a solvate thereof, a treatment effective quantity of oxycodone or a pharmaceutically acceptable salt thereof and an optional pharmaceutically acceptable carrier. The invention further relates to a use of the composition containing the treatment effective quantity of lappaconitine or the pharmaceutically acceptable salt thereof or the solvate thereof and the treatment effective quantity of oxycodone or the pharmaceutically acceptable salt thereof in the preparation of medicines for relieving pain. The pharmaceutical composition and the use, disclosed by the invention, have the beneficial effects as described in the specification.

Description

technical field [0001] The invention belongs to the technical field of medicines, and relates to a pharmaceutical composition for preventing or treating pain, in particular to a pharmaceutical composition containing homogenate and oxycodone. Background technique [0002] Pain is an unpleasant sensory and emotional experience that occurs when the body is damaged. It is a clinical manifestation of a group of complex pathological and physiological changes. Pain can be local or a reflection of systemic diseases. Diseases in which "pain" is the main symptom are collectively referred to as "pain". In addition, some strong analgesics are often used clinically, for example, for pain caused by postoperative, trauma, cancer, etc. However, many analgesics are prone to dependence / addiction, and once mental dependence occurs, it will bring new and bigger problems to clinical medication. [0003] Lappaconitine (LA), also known as aconitine and labaconitine, as a long-acting analgesic, i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/485A61K31/439A61P29/00A61P25/04
Inventor 高永良李莉娥孙建宁刘泽源
Owner BEIJING HUMANWELL JUNWEI PHARM TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com